MedPath

Treatment with phytoesterogen on vaginal atrophy in postmenopausal wome

Not Applicable
Conditions
Atrophy Vaginal inpost menopausal women.
Postmenopausal Atrophic Vaginitis
Registration Number
IRCT2014102919743N1
Lead Sponsor
Vice chancellor for research, Ahvaz JundiShapur University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

inclusion criteria: Age between 45 to 65, Amenorrhea at less 12 month or have hormone test with FSH level more than 40 unit, Presenting symptom of vaginal atrophy, Have Sexual activity and single partner? Exclusion criteria: Vaginal infection, Genital Abnormalities, The use of Sex Hormones within the 8 weeks preceding study, user of smoke and alcohol and etc ? Genital Bleeding or spotting of unknown Cause, Use of Phytoestrogens such as Soy, Red clover, Fenugreek, Vitex within the last one Month

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vaginal Atrophy. Timepoint: Before intervention, Two weeks after the intervention, Four weeks after intervention, Eight weeks after intervention. Method of measurement: Kupperman Index Questionnaire.;Percentage of Maturity vaginal cells. Timepoint: Before and after eight weeks (end of intervention). Method of measurement: Vaginal smear.;Vaginal PH. Timepoint: Before and after eight weeks (end of intervention). Method of measurement: By PH meter strips.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath